Aug 1 (Reuters) - Mabwell Shanghai Bioscience Co Ltd 688062.SS:
MABWELL ANNOUNCES IND APPLICATION ACCEPTANCE FOR CDH17-TARGETING ADC 7MW4911 FROM BOTH NMPA AND FDA
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.